Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates.
Amarin stock last closed at $15.34, down 6.29% from the previous day, and has increased 87.07% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.66 percentage points. Amarin stock is currently +103.88% from its 52-week low of $7.52, and -26.6% from its 52-week high of $20.90.
At the moment, there are 416.08M AMRN shares outstanding. The market value of AMRN is $319.13M. In the last 24 hours, 71,000 AMRN shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy AMRN stock.
In our opinion, eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal details so you are able to invest in AMRN today.
Now that you've created your account on the best stock trading app for beginners, you can securely and quickly fund your account:
Watch the video below if you need help transferring funds into your new investment account.
Once you have figured out the best place to buy Amarin stock, it's critical to research their stock prior to buying, so you truly comprehend the risk as well as the upside.
WallStreetZen was created to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on AMRN's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AMRN's true value.
Using relative valuations metrics:
You can access additional valuation research on AMRN's stock here.
You can dig deeper into what analysts are saying on the Amarin stock forecast page.
Last year, AMRN revenue was $213.65M. In the last five year, AMRN's revenue has gone up by -19.04% per year. This was slower than the Drug Manufacturers - General industry average of 10.09%.
You can analyze AMRN's earnings and revenue performance here.
In the last year, executives and large shareholders at AMRN have sold more shares than they have bought.
Aaron Berg, President and CEO of AMRN, was the latest AMRN insider to sell. They sold $19,043.70 worth of AMRN shares on Jan 31, 2026.
Dig into more about who owns AMRN shares here.
No, Amarin doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main options:
Hit the Open button and your broker will place your order.
If you require more assistance buying stocks on eToro, watch the how to video below:
Now that you own some shares in AMRN, you'll want to keep up with your stock purchase.
Add AMRN to a watchlist to monitor your AMRN stock.
To reiterate, here are the 6 steps you need to take to buy Amarin stock right now:
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Amarin, add AMRN to your watchlist by clicking the button below.